Tetraf-P Injection
L-Leucine 0.74g · L-Lysine Acetate 0.93g +25 more
Injections · Prescription medication · Combination
Daehan Pharmaceutical Co., Ltd.
MFDS item code 202106329 · Notified 2021.09.02
Improvement of nutritional deficiencies through intravenous nutritional support (calories, amino acids, essential fatty acids, etc.)
This medication is used in cases where nutrition cannot be supplied orally or through the gastrointestinal tract in children over 2 years of age and adults. It helps improve the body's nutritional status by appropriately supplying calories, amino acids, essential fatty acids, and omega-3 fatty acids. Through this, it regulates nutritional imbalances in patients and supports health recovery. Nutritional support is administered intravenously to ensure that patients receive the necessary essential nutrients on time. Consequently, this medicine is used to effectively manage the nutritional status.
The dose and infusion rate are determined according to the patient's ability to eliminate fat and metabolize nitrogen and glucose, and nutritional requirements. The dose should be individualized in consideration of the patient's condition, body weight, nutritional and energy requirements, and additional oral/enteral intake. Trace elements, vitamins, electrolytes, etc. may be added according to the patient's condition. The nitrogen requirement for maintaining body protein depends on the patient's condition (e.g., nutritional status and catabolic stress or anabolism). Children 12 years and older and adults - Patients with normal nutritional status or mild metabolic stress: amino acids 0.6-0.9 g/kg per day (nitrogen 0.10-0.15 g/kg) - Patients with moderate to high metabolic stress, regardless of nutritional imbalance: amino acids 0.9-1.6 g/kg per day (nitrogen 0.15-0.25 g/kg) In very special cases (e.g., burns or marked anabolic states), nitrogen requirements may be higher. Dose A daily dose of 13-31 mL/kg of this medicine corresponds to amino acids 0.6-1.6 g/kg (nitrogen 0.10-0.25 g/kg) and total energy 14-35 kcal/kg (non-protein energy 12-27 kcal/kg)). This meets the requirements of most patients. In obese patients, the dose should be based on predicted normal body weight. Infusion rate The infusion rate must not exceed 2.0 mL/kg per hour (equivalent to amino acids 0.10 g/kg, glucose 0.25 g/kg, and fat 0.08 g/kg). The recommended infusion duration is 14-24 hours. Maximum daily dose The maximum daily dose depends on the patient's clinical condition and may vary from day to day. The recommended maximum daily dose is 35mL/kg. The recommended maximum daily dose of 35 mL/kg provides amino acids 1.8 g/kg (nitrogen 0.28 g/kg), glucose 4.5 g/kg, fat 1.33 g/kg, and total energy 39 kcal/kg (equivalent to non-protein energy 31 kcal/kg). Administer by intravenous infusion through a central vein.
Children aged 2-11 years: Up to 35 mL/kg of this medicine per day; the recommended maximum daily dose is 35mL/kg, which provides amino acids 1.8 g/kg (as nitrogen, 0.28 g/kg), glucose 4.5 g/kg, fat 1.33 g/kg, and total calories 39 kcal/kg (equivalent to 31 kcal/kg as non-protein calories). The infusion rate should not exceed 2.4 mL/kg per hour (equivalent to amino acids 0.12 g/kg, glucose 0.30 g/kg, and fat 0.09 g/kg). Except in special circumstances, when administered at the recommended maximum infusion rate, careful monitoring is required, and the infusion duration should not exceed 14 hours 30 minutes. The recommended infusion duration is 12-24 hours.
This medication must be used under medical supervision, and administration must be stopped immediately if allergic reactions such as fever, chills, rash, or difficulty breathing occur. When used in conjunction with intravenous calcium-containing preparations, a precipitate may form, so they should not be infused simultaneously using the same infusion device, and the infusion line must be thoroughly cleaned before and after use. This drug may be risky in premature and low-birth-weight infants as its lipid components may not be well eliminated from the body. Patients with allergies to fish, eggs, soybeans, peanuts, or those with severe liver, kidney, or blood disorders, as well as those in acute shock, should not use this medication. Patients with specific conditions such as renal failure, diabetes, or impaired liver function should use this drug cautiously, and blood glucose, electrolyte, liver enzyme levels, etc., should be monitored frequently during administration. Care should be taken not to allow blood lipid levels to rise too high during administration, and dosages should be adjusted or stopped if any abnormal symptoms occur. Side effects such as hyperlipidemia, allergic reactions, nausea, vomiting, headaches may occur, so abnormal symptoms should be closely observed. This drug has not been established for safety in pregnant or breastfeeding women, and must only be used when absolutely necessary under a physician's discretion. Because it can affect blood test results, it is advisable to draw blood 5-6 hours after administration when conducting tests. In case of overdose, slow down the infusion rate or stop it, as there are no specific antidotes, supportive care according to symptoms is necessary. This drug should be stored below 25 degrees Celsius in a sealed container to protect it from air or moisture, and must be used immediately after mixing or within 24 hours if refrigerated.
Fever, chills, rash, difficulty breathing, tachycardia, difficulty breathing, loss of appetite, nausea, vomiting, increased plasma enzyme levels, thrombus venous inflammation, hypotension, hypertension, mild elevation of body temperature, chills, headache, dizziness, anaphylactic or anaphylactoid reaction, skin rash, urticaria, flushing, headache, feeling of warmth, coldness, cyanosis, pallor, pain (in the neck, back, bones, chest, lumbar), obesity syndrome, hyperlipidemia, fever, fatty infiltration, jaundice, hepatomegaly, splenomegaly, anemia, leukopenia, thrombocytopenia, coagulation disorders, hemolysis, reticulocytosis, abnormal liver function test results, coma, nausea, vomiting, chills, sweating, rise in body temperature, hyperglycemia, allergic reactions, constipation, diarrhea, pneumonia, stomatitis, delirium, dyspepsia, abdominal pain, hypoalbuminemia, insomnia, febrile neutropenia, generalized weakness, edema, urinary disorders, hematuria, weight loss, hypoglycemia, hypocalcemia, heartburn, aspiration pneumonia, hematemesis, runny nose, extravasation at the injection site, phlebitis, procedural site reaction, dysuria, cough, infection, thromboembolism, bloody stool, vasculitis, skin infection, pulmonary edema, sepsis, Clostridium infection, candidiasis, dental disease, pancreatitis, weight gain, fluid overload, spinal compression, vaginal bleeding, interstitial fluid retention, hyponatremia, bowel obstruction, cervical cancer, gum bleeding, pharyngeal disease, depression, pressure ulcers, urinary incontinence, urinary tract infection, malnutrition, laceration, gastroesophageal reflux disease, aspergillosis, oral thrush, neuropathic pain, neuropathy, esophagitis, vesicles, wound infection, upper abdominal pain, frequent urination, anxiety, ascites, abdominal discomfort, atelectasis, peripheral neuropathy, hiccups, colitis, leg edema, cerebral ischemia, acute renal failure, myalgia, hypersensitivity, exacerbation of hypertension, conjunctival hemorrhage, hemoptysis, sputum disease, voice disorders
Not everyone experiences these, and they can vary from person to person.
This drug must be stored in a sealed container to protect it from air and moisture. Additionally, to maintain the drug's effectiveness, it should be stored in a cool place below 25 degrees Celsius, taking care not to freeze it.
It consists of a colorless and transparent intravenous plastic bag divided into three separable pouches, with an oxygen-absorbing agent placed in between. Each inner pouch contains a colorless to slightly yellowish transparent amino acid solution.
1477 mL/bag (Solution A 750 mL, Solution B 446 mL, Solution C 281 mL)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
L-Leucine 0.74g · L-Lysine Acetate 0.93g +25 more
Injections · Prescription medication · Combination
Daehan Pharmaceutical Co., Ltd.
L-Leucine 0.74g · L-Lysine Acetate 0.93g +25 more
Injections · Prescription medication · Combination
Daehan Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.